|1.||Vollrath, Valeska: 1 article (08/2006)|
|2.||Farias, Marcelo: 1 article (08/2006)|
|3.||Wielandt, Ana M: 1 article (08/2006)|
|4.||Chianale, Jose: 1 article (08/2006)|
|1.||Hepatocellular Carcinoma (Hepatoma)
08/14/2006 - "We tested the hypothesis that bucillamine and its oxidized metabolite SA 981 also activate the Nrf2 pathway, thereby increasing glutathione biosynthesis in human HepG2 and murine Hepa 1-6 hepatoma cell lines, through the induction of the GCLC enzyme as well as the Mrp2/MRP2 transporter, which mediates the excretion of glutathione and its conjugates from hepatocytes. "
|1.||Glutathione (Reduced Glutathione)
|2.||bucillamine (SA 96)